{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T16:31:11Z","timestamp":1761323471771},"reference-count":17,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The tuberculin skin test (TST) was compared with QuantiFERON-TB Gold in-tube (QFT-GIT) test for the diagnosis of tuberculosis in non-\n            <jats:italic>Mycobacterium bovis<\/jats:italic>\n            BCG-vaccinated military personnel. Among subjects positive by TST, 44.4% of recruits were positive by QFT-GIT compared with 11.5% subjects tested after missions abroad, suggesting that most TST conversions in the latter group were caused by nontuberculous mycobacteria.\n          <\/jats:p>","DOI":"10.1128\/cvi.00463-06","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T01:37:39Z","timestamp":1171503459000},"page":"477-480","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":34,"title":["Comparison of Mantoux and QuantiFERON TB Gold Tests for Diagnosis of Latent Tuberculosis Infection in Army Personnel"],"prefix":"10.1128","volume":"14","author":[{"given":"Willeke P. J.","family":"Franken","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands"},{"name":"Coordinating Center Expert Military Health Care of the Royal Dutch Armed Forces, Hollandse Rading, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost F.","family":"Timmermans","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands"},{"name":"Coordinating Center Expert Military Health Care of the Royal Dutch Armed Forces, Hollandse Rading, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corine","family":"Prins","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands"},{"name":"Coordinating Center Expert Military Health Care of the Royal Dutch Armed Forces, Hollandse Rading, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evert-Jan H. J.","family":"Slootman","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands"},{"name":"Coordinating Center Expert Military Health Care of the Royal Dutch Armed Forces, Hollandse Rading, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Dreverman","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands"},{"name":"Coordinating Center Expert Military Health Care of the Royal Dutch Armed Forces, Hollandse Rading, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Bruins","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands"},{"name":"Coordinating Center Expert Military Health Care of the Royal Dutch Armed Forces, Hollandse Rading, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap T.","family":"van Dissel","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands"},{"name":"Coordinating Center Expert Military Health Care of the Royal Dutch Armed Forces, Hollandse Rading, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra M.","family":"Arend","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands"},{"name":"Coordinating Center Expert Military Health Care of the Royal Dutch Armed Forces, Hollandse Rading, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","volume":"356","year":"2000","unstructured":"Andersen, P., M. E. Munk, J. M. Pollock, and T. M. Doherty. 2000. Specific immune-based diagnosis of tuberculosis. Lancet356:1099-1104.","journal-title":"Lancet"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200608-1099OC"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0962-8479(95)90531-6","volume":"76","year":"1995","unstructured":"Bruins, J., J. H. Gribnau, and R. Bwire. 1995. Investigation into typical and atypical tuberculin sensitivity in the Royal Netherlands Army, resulting in a more rational indication for isoniazid prophylaxis. Tuber. Lung Dis.76:540-544.","journal-title":"Tuber. Lung Dis."},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1465-9921-7-77","volume":"7","year":"2006","unstructured":"Diel, R., A. Nienhaus, C. Lange, K. Meywald-Walter, M. Forssbohm, and T. Schaberg. 2006. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir. Res.7:77.","journal-title":"Respir. Res."},{"key":"e_1_3_2_6_2","first-page":"267","volume":"54","year":"2006","unstructured":"Dogra S., P. Narang, D. K. Mendiratta, P. Chaturvedi, A. L. Reingold, J. M.Colford, Jr., et al. 2006. Comparison of a whole blood interferon-\u03b3 assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J. Infect.54:267-276.","journal-title":"J. Infect."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(06)68579-6","volume":"367","year":"2006","unstructured":"Ferrara, G., M. Losi, R. D'Amico, P. Roversi, R. Piro, M. Meacci, et al. 2006. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet367:1328-1334.","journal-title":"Lancet"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.1.16-22.1996"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1001\/jama.293.22.2756","volume":"293","year":"2005","unstructured":"Kang, Y. A., H. W. Lee, H. I. Yoon, B. Cho, S. K. Han, Y. S. Shim, et al. 2005. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA293:2756-2761.","journal-title":"JAMA"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1473-3099(05)70118-3","volume":"5","year":"2005","unstructured":"Lalvani, A., L. Richeldi, and H. Kunst. 2005. Interferon gamma assays for tuberculosis. Lancet Infect. Dis.5:322-324.","journal-title":"Lancet Infect. Dis."},{"key":"e_1_3_2_11_2","first-page":"49","volume":"54","year":"2005","unstructured":"Mazurek, G. H., J. Jereb, P. Lobue, M. F. Iademarco, B. Metchock, and A. Vernon. 2005. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. Morb. Mortal. Wkly. Rep.54:49-55.","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3201\/eid1209.051606","volume":"12","year":"2006","unstructured":"Nakaoka, H., L. Lawson, S. B. Squire, B. Coulter, P. Ravn, I. Brock, et al. 2006. Risk for tuberculosis among children. Emerg Infect. Dis.12:1383-1388.","journal-title":"Emerg Infect. Dis."},{"key":"e_1_3_2_13_2","unstructured":"National Collaborating Centre for Chronic Conditions. 2006. Tuberculosis: clinical diagnosis and management of tuberculosis and measures for its prevention and control. Royal College of Physicians London United Kingdom."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1164\/rccm.200604-472OC","volume":"174","year":"2006","unstructured":"Pai M., R. Joshi, S. Dogra, D. K. Mendiratta, P. Narang, S. Kalantri, et al. 2006. Serial testing of health care workers for tuberculosis using interferon-\u03b3 assay. Am. J. Respir. Crit. Care Med.174:349-355.","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1586\/14737159.6.3.423","volume":"6","year":"2006","unstructured":"Pai, M., S. Kalantri, and K. Dheda. 2006. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev. Mol. Diagn.6:423-432.","journal-title":"Expert Rev. Mol. Diagn."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","volume":"4","year":"2004","unstructured":"Pai, M., L. W. Riley, and J. M. Colford, Jr. 2004. Interferon-\u03b3 assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis.4:761-776.","journal-title":"Lancet Infect. Dis."},{"key":"e_1_3_2_17_2","unstructured":"Petrie A. and C. Sabin. 2006. Medical statistics at a glance 2nd ed. Blackwell Publishing Oxford United Kingdom."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1586\/14787210.3.6.981","volume":"3","year":"2005","unstructured":"Rothel, J. S., and P. Andersen. 2005. Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent? Expert Rev. Anti-Infect Ther.3:981-993.","journal-title":"Expert Rev. Anti-Infect Ther."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00463-06","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00463-06","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:38:23Z","timestamp":1627591103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00463-06"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1128\/CVI.00463-06"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00463-06","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"2006-12-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-02-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}